Skip to content

Reliable Intravenous Access by Line Experts (RELIABLE): a pilot trial

Reliable Intravenous Access by Line Experts (RELIABLE): a pilot randomised controlled trial to compare peripheral venous catheter insertion by vascular access specialists with any clinician (generalist model, standard practice) on clinical and economic outcomes among medical and surgical patients.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12616001675415
Acronym
The RELIABLE Trial
Enrollment
138
Registered
2016-12-06
Start date
2017-07-21
Completion date
2017-11-10
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Successful peripheral venous catheter (PVC) insertion and the decrease of catheter related complications that result in device failure is an important clinical objective and patient outcome. Although previous studies have identified the level of skill of the PVC inserter as a risk factor for catheter failure there is a paucity of information investigating the impact of a Vascular Access Specialist (VAS). We will use a single centre, randomised controlled trial to compare the clinical and economic outcomes of PVC inserted by a VAS against those inserted by a generalist inserter (standard care). As this is a pilot study, the primary aim of this study is to establish feasibility of the protocol and the planned processes. This will help to budget and plan correctly for the larger definitive trial. We will collect data on the success of screening and recruitment strategies; test our data collection processes and technology; cost the Research Nurse time required for the trial; and finalise sample size requirements for the larger trial. Participants will be eligible for inclusion in this trial if they are a medical or surgical patient over the age of 18 and are having a peripheral intravenous catheter inserted as part of their therapy (which is expected to remain in place for at least 24 hours). All participants enrolled in this trial will be randomly allocated (by chance) to have their PVC inserted by either a Vascular Access Specialist or a generalist inserter. Daily follow ups will then be carried out by a (blinded) Research Nurse until the time of device removal.

Interventions

Patients from the medical and surgical departments who require a peripheral intravenous catheters (PVC) for longer than 24 hours will be eligible for inclusion in this study. Consenting patients will have their PVC inserted by a Vascular Access Specialist (intervention) or a generalist clinician (control). Arm 1 (control): PVC inserted as per hospital policy by a credentialed PVC inserter (generalist approach). Arm 2 (intervention): Vascular Access Specialist (VAS), defined as a registered nur

Patients from the medical and surgical departments who require a peripheral intravenous catheters (PVC) for longer than 24 hours will be eligible for inclusion in this study. Consenting patients will have their PVC inserted by a Vascular Access Specialist (intervention) or a generalist clinician (control). Arm 1 (control): PVC inserted as per hospital policy by a credentialed PVC inserter (generalist approach). Arm 2 (intervention): Vascular Access Specialist (VAS), defined as a registered nurse with advanced knowledge of vascular access including catheter technology, dressings, modalities of catheter access and intravenous therapy management.

Sponsors

Griffith University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patient requires a PVC for greater than 24 hours =>the age of 18 (no upper limit) Able to provide written informed consent

Exclusion criteria

Current blood stream infection (within 48 hours of study entry). Previous enrolment on the study. Patients on a palliative care pathway and/or receiving critical care treatment.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 23, 2026